What is the protocol if a patient misses their second Penicillin (Penicillin G) injection by a week, when they require a series of 3 injections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Protocol for Missed Penicillin G Injection in a 3-Injection Series

If a patient misses their second Penicillin G injection by a week in a 3-injection series, they should resume the sequence of injections without restarting the entire course, as pharmacologic considerations suggest that an interval of 10-14 days between doses is acceptable for late syphilis or latent syphilis of unknown duration. 1

Management Algorithm for Missed Penicillin G Injection

Assessment of Patient Factors:

  1. Determine if the patient is pregnant

    • If pregnant: The entire course of therapy must be repeated 1
    • If not pregnant: Continue with protocol below
  2. Determine type of syphilis being treated

    • Early latent syphilis: Single dose regimen (not applicable to this scenario)
    • Late latent or unknown duration syphilis: Three-dose regimen (applicable to this scenario)

Protocol for Non-Pregnant Patients:

  • Administer the missed second dose immediately
  • Schedule the third dose to be given 1 week after the second dose
  • Document the extended interval between first and second doses
  • Ensure close follow-up with appropriate serologic testing

Rationale and Evidence

The CDC guidelines specifically address this scenario, stating: "If a patient misses a dose of penicillin in the course of weekly therapy for late syphilis, the appropriate course of action is unclear. Pharmacologic considerations suggest that an interval of 10-14 days between doses of benzathine penicillin for late syphilis or latent syphilis of unknown duration might be acceptable before restarting the sequence of injections." 1

This recommendation is based on the pharmacokinetics of benzathine penicillin G, which maintains treponemicidal serum concentrations for 2-3 weeks after injection. The goal of therapy is to maintain adequate serum penicillin levels to treat the infection effectively.

Special Considerations

For Pregnant Patients:

  • Missed doses are not acceptable for pregnant patients receiving therapy for late latent syphilis
  • Pregnant women who miss any dose must repeat the full course of therapy 1
  • This more conservative approach is due to the risk of congenital syphilis

Follow-Up Recommendations:

  • Quantitative nontreponemal serologic tests should be repeated at 6,12, and 24 months 1
  • Monitor for signs of treatment failure:
    • Fourfold increase in titer
    • Failure of initially high titer (>1:32) to decline at least fourfold within 12-24 months
    • Development of signs or symptoms attributable to syphilis

Common Pitfalls to Avoid

  • Unnecessarily restarting the entire course for non-pregnant patients
  • Failing to recognize that pregnant patients require a complete restart of therapy
  • Inadequate follow-up serologic testing
  • Not documenting the extended interval between injections
  • Switching between different nontreponemal tests during follow-up, which can complicate interpretation

By following this protocol, clinicians can ensure appropriate management of patients who miss a dose in their penicillin G treatment series while minimizing the risk of treatment failure and disease progression.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.